UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September 30, 2020~~

March 31, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File

No. 001-39624

TURMERIC ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

~~Cayman Islands~~

~~001-39624~~

~~98-1555727~~

~~(State or other jurisdiction of~~

~~incorporation or organization)~~

~~(Commission~~

~~File Number)~~

~~(I.R.S. Employer~~

~~Identification Number)~~


~~450 Kendall St~~ Cayman Islands		98-1555727
~~Cambridge, MA~~ (State or other jurisdiction of incorporation)		~~02142~~
(~~Address of principal executive offices)~~		~~(Zip Code)~~IRS Employer Identification No.)

450 Kendall St

Cambridge, MA 02142

(Address of principal executive offices, including zip code)

(617)

425-9200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A Ordinary Share, $0.0001 par value, and one-third of one redeemable warrant	TMPMU	The Nasdaq Capital Markets
~~Class A Ordinary Shares included as part of the units~~	~~TMPM~~	~~The Nasdaq Capital Markets~~
Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50	TMPMW	The Nasdaq Capital Markets
Class A Ordinary Shares included as part of the units	TMPM	The Nasdaq Capital Markets

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T (§

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.


Large accelerated filer	☐	Accelerated filer	☐

Non-accelerated filer	☒	Smaller reporting company	☒


		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). Yes ☒ No ☐

As of ~~November 30, 2020,~~May

, 2022, 10,190,500 Class A ordinary shares, par value $0.0001, and 2,443,750 Class B ordinary shares, par value $0.0001, were issued and outstanding.

Table of Contents

TURMERIC ACQUISITION CORP.

Quarterly Report on

Form 10-Q

Table of Contents


		Page No.
PART I. FINANCIAL INFORMATION

Item 1.	Condensed Financial Statements		1 2

	~~Unaudited~~ Condensed Balance ~~Sheet~~Sheets as of ~~September 30, 2020~~March 31, 2022 (unaudited) and December 31, 2021		1 2

	Unaudited Condensed ~~Statement~~Statements of Operations for the ~~period from August 28, 2020 (inception) through September 30, 2020~~Three Ended March 31, 2022 and 2021		2 3

	Unaudited Condensed ~~Statement~~Statements of Changes in Shareholders’ Deficit for the ~~period from August 28, 2020 (inception) through September 30, 2020~~Three Months Ended March 31, 2022 and 2021		3 4

	Unaudited Condensed ~~Statement~~Statements of Cash Flows for the ~~period from August 28, 2020 (inception) through September 30, 2020~~Three Months Ended March 31, 2022 and 2021		4 5

	Notes to Unaudited Condensed Financial Statements		5 6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		16 20

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		18 23

Item 4.	Controls and Procedures		18 23

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings		19 25

Item 1A.	Risk Factors		19 25

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds ~~from Registered Securities~~		19 25

Item 3.	Defaults Upon Senior Securities		20 25

Item 4.	Mine Safety Disclosures		20 25

Item 5.	Other Information		20 25

Item 6.	Exhibits		20 26

SIGNATURES			27

Table of Contents

PART ~~I -~~ I—FINANCIAL INFORMATION

Item 1. Condensed Financial Statements.

TURMERIC ACQUISITION CORP.

~~UNAUDITED~~

CONDENSED BALANCE ~~SHEET~~

~~SEPTEMBER 30, 2020~~

Assets

Deferred offering costs
   $ 342,148


Total Assets
   $ 342,148


Liabilities and Shareholders’ Deficit

Current liabilities

Accounts payable
   $ 39,496
Accrued expenses
   270,280
Notes payable - related party
   64,177


Total current liabilities
   373,953
Commitments and Contingencies

Shareholders’ Deficit

Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
   —
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no shares issued and outstanding
   —
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 2,443,750 shares issued and outstanding
   244
Additional paid-in capital
   24,756
Accumulated deficit
   (56,805 )


Total shareholders’ deficit
   (31,805 )


Total Liabilities and Shareholders’ Deficit
   $ 342,148

SHEETS

March 31, 2022

December 31, 2021


(unaudited)

Assets

Current assets

Cash and cash equivalents
   $ 229,835 $ 425,270
Prepaid expenses
   123,375 121,204


Total current assets
   353,210 546,474
Investments held in Trust Account
   97,758,689 97,757,245


Total Assets

$
98,111,899

$
98,303,719



Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit

Current liabilities

Accounts payable
   $ 289,524 $ 215,764
Accrued expenses
   490,268 329,151
Due to related party
   10,000 27,900


Total current liabilities
   789,792 572,815
Derivative warrant liabilities
   1,119,980 2,309,850
Deferred underwriting commissions
   3,421,250 3,421,250


Total Liabilities
   5,331,022 6,303,915
Commitments and Contingencies
   0 0
Class A ordinary shares subject to possible redemption, $0.0001 par value; 9,775,000 shares at redemption value of $10.00 per share as of March 31, 2022 and December 31, 2021
   97,750,000 97,750,000
Shareholders’ Deficit:

Preference shares, $0.0001 par value; 1,000,000 shares authorized; 0ne issued
or
outstanding as of March 31, 2022 and December 31, 2021
   0   0
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 415,500 shares issued and outstanding as of March 31, 2022 and December 31, 2021
   42 42
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 2,443,750 shares issued and outstanding as of March 31, 2022 and December 31, 2021
   244 244
Additional
paid-in
capital
   0   0
Accumulated deficit
   (4,969,409 ) (5,750,482 )


Total Shareholders’ Deficit
   (4,969,123 ) (5,750,196 )


Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit

$
98,111,899

$
98,303,719

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

TURMERIC ACQUISITION CORP.

UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF OPERATIONS

~~FOR THE PERIOD FROM AUGUST 28, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020~~

General and administrative expenses
   $ 56,805


Loss from operations
   (56,805 )


Net loss
   $ (56,805 )


Weighted average shares outstanding, basic and diluted
   2,443,750


Basic and diluted net loss per share
   $ (0.02 )

Three Months Ended March 31,


2022

2021

Operating expenses:

General and administrative expenses
   $ 380,241 $ 180,989
Administrative fee - related party
   30,000 30,000


Loss from operations
   (410,241 ) (210,989 )
Other income:

Change in fair value of derivative warrant liabilities
   1,189,870 2,894,233
Net income earned on investments held in Trust Account
   1,444 1,444


Net income
   $ 781,073 $ 2,684,688


Weighted average shares outstanding of Class A ordinary shares, basic and diluted
   10,190,500 10,190,500


Basic and diluted net income per share, Class A ordinary shares
   $ 0.06 $ 0.21


Weighted average shares outstanding of Class B ordinary shares, basic and diluted
   2,443,750 2,443,750


Basic and diluted net income per share, Class B, ordinary shares
   $ 0.06 $ 0.21

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

TURMERIC ACQUISITION CORP.

UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE ~~PERIOD FROM AUGUST 28, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020~~

   Ordinary Shares    Additional
Paid-in
Capital    Total
Shareholders’
Deficit
   Class A    Class B    Accumulated
Deficit
   Shares    Amount    Shares    Amount
Balance - August 28, 2020 (inception)
   —      $ —      —      $ —      $ —      $ —   $ —
Issuance of Class B ordinary shares to Sponsor
   —      —      2,443,750    244    24,756    —   25,000
Net loss (unaudited)
   —      —      —      —      —      (56,805 ) (56,805 )












Balance - September 30, 2020 (unaudited)
   —      $ —      2,443,750    $ 244    $ 24,756    $ (56,805 ) $ (31,805 )

THREE MONTHS ENDED MARCH 31, 2022

Ordinary Shares

Additional

Total


Class A

Class B

Paid-in

Accumulated

Shareholders’


Shares

Amount

Shares

Amount

Capital

Deficit

Deficit

Balance - December 31, 2021


415,500


$
42



2,443,750


$
244

   $ 0
$
(5,750,482
)

$
(5,750,196
)
Net income
   —      —      —      —

0

   781,073 781,073












Balance - March 31, 2022 (unaudited)


415,500


$
42



2,443,750


$
244

   $ 0
$
(4,969,409
)

$
(4,969,123
)












FOR THE THREE MONTHS ENDED MARCH 31, 2021

Ordinary Shares

Total


Class A

Class B

Additional Paid-In

Accumulated

Shareholders’


Shares

Amount

Shares

Amount

Capital

Deficit

Deficit

Balance - December 31, 2020


415,500


$
42



2,443,750


$
244

   $ 0
$
(8,405,360
)

$
(8,405,074
)
Net income
   —      —      —      —      —      2,684,688 2,684,688












Balance - March 31, 2021 (unaudited)


415,500


$
42



2,443,750


$
244

   $ 0
$
(5,720,672
)

$
(5,720,386
)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

TURMERIC ACQUISITION CORP.

UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF CASH FLOWS

~~FOR THE PERIOD FROM AUGUST 28, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020~~

Cash Flows from Operating Activities:

Net loss
   $ (56,805 )
Adjustments to reconcile net loss to net cash used in operating activities:

General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares
   25,000
General and administrative expenses paid by Sponsor under note payable
   23,500
Changes in operating assets and liabilities:

Accrued expenses
   8,305


Net cash used in operating activities
   —


Net increase in cash
   —
Cash - beginning of the period
   —


Cash - end of the period
   $ —


Supplemental disclosure of noncash financing activities:

Deferred offering costs included in accounts payable
   $ 39,496
Deferred offering costs included in accrued expenses
   $ 261,975
Deferred offering costs included in note payable - related party
   $ 40,677

Three Months Ended March 31,


2022

2021

Cash Flows from Operating Activities:

Net income
   $ 781,073 $ 2,684,688
Adjustments to reconcile net income to net cash used in operating activities:

Net income earned on investments held in Trust Account
   (1,444 ) (1,444 )
Change in fair value of derivative warrant liabilities
   (1,189,870 ) (2,894,233 )
Changes in operating assets and liabilities:

Prepaid expenses
   (2,171 ) 2,267
Accounts payable
   73,760 101,855
Accrued expenses
   161,117 (78,587 )
Due to related party    (17,900 ) —


Net cash used in operating activities
   (195,435 ) (185,454 )


Net change in cash and cash equivalents
   (195,435 ) (185,454 )
Cash and cash equivalents - beginning of the period    425,270 1,196,877


Cash and cash equivalents - end of the period
$
229,835

$
1,011,423

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

TURMERIC ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1—1 — Description of Organization and Business Operations ~~and Basis of Presentation~~

Turmeric Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on August 28, 2020. The Company was ~~formed~~incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

As of ~~September 30, 2020,~~March 31, 2022, the Company had not commenced any operations. All activity for the period from August 28, 2020 (inception) through ~~September 30, 2020~~March 31, 2022 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate

non-operating

income in the form of interest income on ~~cash and cash equivalents from~~ the proceeds derived from the Initial Public Offering. ~~The Company has selected December 31 as its fiscal year end.~~

The Company’s sponsor is Turmeric Management, LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering became effective on October 15, 2020. On October 20, 2020, the Company consummated its Initial Public Offering of 9,775,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 1,275,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of approximately $97.8 million, and incurring offering costs of approximately $5.9 million, inclusive of approximately $3.4 million in deferred underwriting commissions ~~(Note~~(

see

Note 5).

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 415,500 units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”), at a price of $10.00 per Private Placement Unit with the Sponsor, generating gross proceeds of approximately $4.2 million ~~(Note~~(

see

Note 4).

Upon the closing of the Initial Public Offering and the Private Placement, approximately $97.8 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and will be invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”) having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier ~~of:~~of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company ~~Act~~Act.

Table of ~~1940, as amended (the “Investment Company Act”).~~

Contents

The Company will provide the holders (the “Public Shareholders”) of its Class A ordinary shares, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a ~~shareholder~~general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes). The

per-share

amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares will be classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards ~~Board’s~~Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 ~~“Distinguishing~~

“Distinguishing Liabilities from ~~Equity.”~~Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, ~~only if~~in the case of a shareholder vote, a majority of the ordinary shares ~~represented in person or by proxy and entitled to vote thereon,~~ voted at a ~~shareholder~~general meeting are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company will adopt upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) have agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the initial shareholders have agreed to waive their redemption rights with respect to their Founder Shares, private placement shares (the “Private Placement Shares”) underlying the Private Placement Units and Public Shares in connection with the completion of a Business Combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.

The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete its Business Combination within 24 months from the closing of the Initial Public Offering, or October 20, 2022 (the “Combination Period”) or with respect to any other provision relating to the rights of Public Shareholders, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

If the Company has not completed a Business Combination within 24 months from the ~~Combination Period,~~closing of the Initial Public Offering (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in ~~the~~each case ~~of clauses (ii) and (iii),~~ to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to consummate a Business Combination within the Combination Period.

Table of Contents

The initial shareholders have agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the trust assets. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Note 2 — Basis of Presentation

and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying ~~unaudited~~ condensed financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ~~generally accepted accounting principles~~of America (“~~U.S.~~ GAAP”) for interim financial information and Article 810 of Regulation

S-X.

Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these financial statements as they doare not ~~include all~~required for interim financial statements under GAAP and the rules of the ~~information and footnotes required by U.S. GAAP.~~SEC. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the ~~period from August 28, 2020 (inception) through September 30, 2020~~three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the ~~period~~year ending December 31, ~~2020.~~

2022 or any future period.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K

for the year ended December 31, 2021, as filed with the SEC on March 29, 2022, which contains the audited financial statements and notes ~~thereto included~~thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on Form~~8-K~~ ~~and~~

10-K

for the ~~final prospectus~~year ended December 31, 2021, as filed ~~by the Company~~ with the SEC on March 29, 2022.

Going-Concern

As of March 31, 2022, the Company had approximately $230,000 in the operating bank account and a working capital deficit of approximately $437,000.

Table of Contents

The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from the Sponsor to cover certain of the Company’s expenses in exchange for the issuance of the Founder Shares (as defined below in Note 4), the loan of approximately $64,000 from the Sponsor under the Note (as defined below in Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on October ~~26, 2020~~20, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined below in Note 4). As of March 31, 2022, there were 0 amounts outstanding under any Working Capital Loan.

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic

205-40,

“Presentation of Financial Statements—Going Concern,” management has determined that the liquidity condition and mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to complete a Business Combination by October ~~16, 2020, respectively.~~

20, 2022, then the Company will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after October 20, 2022. The Company intends to complete a business combination in this timeframe.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such an election to opt out is irrevocable.

The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

~~Risk and Uncertainties~~

~~On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the~~ ~~“COVID-19~~ ~~outbreak”). In March 2020, the WHO classified the~~ ~~COVID-19~~ ~~outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the~~ ~~COVID-19~~ ~~outbreak continues to evolve. The impact of the~~ ~~COVID-19~~ outbreak on the Company’s results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the ~~COVID-19~~ outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s results of operations, financial position and cash flows may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the ~~COVID-19~~ outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an Initial Business Combination in a timely manner. The Company’s ability to consummate an initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the ~~COVID-19~~ ~~outbreak and the resulting market downturn.~~

~~Liquidity and capital resources~~

~~As of September 30, 2020, the Company had no cash and working capital deficit of approximately $374,000.~~

The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from the Sponsor to cover certain of the Company’s expenses in exchange for the issuance of the Founder Shares, the loan of approximately $64,000 from the Sponsor under the Note (see Note 4), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on October 20, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). As of September 30, 2020, there were no amounts outstanding under any Working Capital Loan.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds held outside of the Trust Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

~~Note 2—Summary of Significant Accounting Policies~~

Use of Estimates

The preparation of financial statements in conformity with ~~U.S.~~ GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

and liabilities at the date of the condensed financial statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. ~~Accordingly,~~One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Table of Contents

Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. As of March 31, 2022 and December 31, 2021, the Company had approximately $230,000 and $425,000
of
cash equivalents, respectively.
Investments Held in Trust Account
The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S.
government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of
money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the
condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities
are

included in net income earned on investments held in the Trust Account in the accompanying condensed statements of operations. The estimated fair
values of investments held in the Trust Account are determined using available market information.
Fair Value Measurement
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.
The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These consist of:
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurements, ~~and Disclosures,~~” equals or approximates the carrying amounts represented in the ~~unaudited~~ condensed balance ~~sheet.~~

~~Deferred~~ sheets, except for derivative warrant liabilities (see Note 9 Derivative Warrant Liabilities is in Note 6).

Table of Contents

Offering Costs Associated with the Initial Public Offering

~~Deferred offering~~

Offering costs consisted of legal, accounting, underwriting ~~fees~~commissions and other costs incurred ~~through the balance sheet date~~ that were directly related to the Initial Public Offering. Offering ~~and that~~costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with derivative warrant liabilities are expensed as incurred, presented as

non-operating

expenses in the condensed statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to ~~shareholders’ deficit~~possible redemption upon the completion of the Initial Public ~~Offering on October 20, 2020.~~

~~Income Taxes~~

Offering. The Company classifies deferred underwriting commissions as

non-current

liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is

re-assessed

at the end of each reporting period. Derivative warrant liabilities are classified as

non-current

liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject to

re-measurement

at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed statements of operations. The fair value of the Public Warrants and Private Placement Warrants were initially measured at fair value using a Monte Carlo simulation model, and the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each subsequent measurement date. The fair value of Public Warrants has subsequently been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly. Derivative warrant liabilities are classified as

non-current

liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ deficit. The Company’s Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2022 and December 31, 2021, 9,775,000 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.

Under ASC 480, the Company has elected to recognize changes in the redemption value immediately as they occur and adjust the carrying value of the security to equal the redemption value at the end of the reporting period. This method views the end of the reporting period as if it were also the redemption date of the security. Effective with the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional

paid-in

capital (to the extent available) and accumulated deficit.

Income Taxes

FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be ~~more likely than not~~

more-likely-than-not

to be sustained upon examination by taxing authorities. ~~There were no unrecognized tax benefits as of September 30, 2020.~~ The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. NoThere were no unrecognized tax benefits and no amounts ~~were~~ accrued for ~~the payment of~~ interest and penalties as of ~~September 30, 2020.~~March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. ~~The Company is subject to income tax examinations by major taxing authorities since inception.~~

Table of Contents

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s ~~unaudited~~ condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve ~~months.~~

months

Net Income (
L
oss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net ~~loss~~income (loss) per ordinary share is ~~computed~~calculated by dividing the net ~~loss~~income (loss) by the weighted average number of ordinary shares outstanding ~~during~~for the respective period. As

The calculation of ~~September 30, 2020,~~diluted net income (loss) per ordinary share does not consider the ~~Company did not have any dilutive securities~~effect of the outstanding Public Warrants and ~~other contracts that could, potentially, be exercised or converted into~~the Private Placement Warrants to purchase an aggregate of 3,396,833 Class A ordinary shares because their exercise is contingent upon future events and ~~then share in~~their inclusion would be anti-dilutive under the ~~earnings of the Company.~~treasury stock method. As a result, diluted ~~loss~~net income (loss) per ordinary share is the same as basic ~~loss~~net income (loss) per ordinary share for the three months ended March 31, 2022 and 2021. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.

The table below presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for ~~the periods presented.~~

each class of ordinary shares:

For
t
he Three Months Ended March 31, 2022

For
t
he
Three Months Ended March 31,

2021


Class A

Class B

Class A

Class B

Basic and diluted net income per ordinary share:

Numerator:

Allocation of net income
   $ 629,996    $ 151,077    $ 2,165,409    $ 519,279
Denominator:

Basic and diluted weighted average ordinary shares outstanding
   10,190,500    2,443,750    10,190,500    2,443,750








Basic and diluted net income per ordinary share
   $ 0.06    $ 0.06    $ 0.21    $ 0.21

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting ~~pronouncement~~standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Note 3—3 — Initial Public Offering

On October 20, 2020, the Company consummated its Initial Public Offering of 9,775,000 Units, including 1,275,000 Over-Allotment Units, at $10.00 per Unit, generating gross proceeds of approximately $97.8 million, and incurring offering costs of approximately $5.9 million, inclusive of approximately $3.4 million in deferred underwriting commissions.

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

Each Unit consists of one Class A ordinary share, and

one-third

of one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 6).

Table of Contents

Note 4—Related Party Transactions

Founder Shares

On September 1, 2020, the Sponsor paid $25,000 to cover certain expenses of the Company in consideration of 2,875,000 Class B ordinary shares, par value $0.0001, (the “Founder Shares”). On October 12, 2020, the Sponsor effected a surrender of 431,250 Class B ordinary shares to the Company for no consideration, resulting in a decrease in the total number of Class B ordinary shares outstanding from 2,875,000 to 2,443,750. The Sponsor agreed to forfeit up to 318,750 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares (excluding the Private Placement Shares and assuming the initial shareholders do not purchase any units in the Initial Public Offering) after the Initial Public Offering. On September 25, 2020, the Sponsor transferred 25,000 Class B ordinary shares to each of the

non-employee

directors and 45,000 Class B ordinary shares to Matthew Roden, as ~~Chairman.~~Chairman, for $0.01 per share. On September 30, 2020, the Sponsor transferred 17,500 Class B ordinary shares to Vinay ~~Bhaskar.~~Bhaskar for $0.01 per share. On April 30, 2021, the Sponsor repurchased 17,500 shares from Dr. Bhaskar, for $0.01 per share, upon Dr. Bhaskar’s resignation as the Company’s Chief Operating Officer. The underwriters fully exercised the over-allotment option on October 20, 2020; thus, these Founder Shares are no longer subject to forfeiture.

The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur ~~of:~~of
(A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Private Placement Units

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 415,500 Private Placement Units, at a price of $10.00 per Private Placement Unit with the Sponsor, generating gross proceeds of approximately $4.2 million. The Private Placement Units (including the Private Placement Shares, the Private Placement Warrants (as defined below) and Class A ordinary shares issuable upon exercise of such warrants) will not be transferable or salable until 30 days after the completion of the initial Business Combination.

Each whole private placement warrant underlying the Private Placement Units (the “Private Placement Warrants”) is exercisable for ~~one~~1 whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the Private Placement Units was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Units and the underlying securities will expire worthless. The Private Placement Warrants will be

non-redeemable ~~(except~~

(except as described in Note 6 below under “Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00”) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Units until 30 days after the completion of the initial Business Combination.

Related Party Loans

On September 1, 2020, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan ~~was non-interest bearing and~~ ~~payable upon the completion of the Initial Public Offering. The Company borrowed approximately $89,000 under the Note and repaid in full on October 20, 2020.~~

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

In ~~addition, in~~ order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business

Table of Contents

Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. ~~To date,~~As of March 31, 2022 and December 31, 2021, the Company had no outstanding borrowings under the Working Capital Loans.

Administrative Support Agreement

Commencing on the effective date of the Company’s prospectus through the earlier of consummation of the initial Business Combination or the Company’s liquidation, the Company will reimburse the Sponsor for office space, secretarial and administrative services provided to the Company in
the amount of $10,000 per month.

The Company incurred $30,000 in expenses in connection with these services during the three months ended March 31, 2022 and 2021, which are included in administrative

fee-related

party on the accompanying condensed statements of operations. As of March 31, 2022 and December 31, 2021,

amounts of

approximately $10,000 and $27,900

are

outstanding, respectively, in connection with these serv

es, included in due to related party on the accompanying condensed balance sheets.

In addition, the Company agreed to reimburse the Sponsor, executive officers and directors, or their respective affiliates for any

out-of-pocket

expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors, or their affiliates.

The Company also agreed to pay (i) the Company’s

non-employee

directors who will receive an annual cash ~~retainer~~compensation of $20,000 and a ~~one-time~~

onetime

cash payment of $30,000 to be paid upon the consummation of the initial Business Combination, and (ii) Matthew Roden, as Chairman, will receive an annual cash retainer of $40,000 and a ~~one-time~~

onetime

cash payment of $60,000 to be paid upon the consummation of the initial Business Combination. Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, will be paid by the Company to the Sponsor, executive officers and directors, or their respective affiliates, prior to completion of the initial Business Combination.

Indication of Interest

The Sponsor and its affiliates have indicated an interest to purchase up to an aggregate of $15.0 million of the Company’s ordinary shares in a private placement that would occur concurrently with the consummation of the initial Business Combination. However, because indications of interest are not binding agreements or commitments to purchase, the Sponsor may determine not to purchase any such shares, or to purchase fewer shares than it has indicated an interest in purchasing. Furthermore, the Company is not under any obligation to sell any such shares. Such investment would be made on terms and conditions determined at the time of the Business Combination.

Each whole Private Placement Warrant underlying the Private Placement Units is exercisable for one whole share of Class A ordinary shares at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Units to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Units and the underlying securities will expire worthless. The Private Placement Warrants will be ~~non-redeemable for~~ ~~cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.~~

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

Note 5—Commitments and Contingencies

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these condensed financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these condensed financial statements.

Registration Rights

The holders of Founder Shares, Private Placement Units, Private Placement Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans), are entitled to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s

Table of Contents

completion of its Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable

lock-up

period, which occurs (i) in the case of the Founder Shares, in accordance with the letter agreement the Company’s initial shareholders entered into and (ii) in the case of the Private Placement Warrants and the respective Class A ordinary shares underlying such warrants, 30 days after the completion of the Company’ s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a

45-day

option from the final prospectus relating to the Initial Public Offering to purchase up to 1,275,000 additional Units to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised the over-allotment option on October 20, 2020.

The underwriters were entitled to an underwriting discount of $0.20 per Unit, or approximately $2.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $3.4 million in the aggregate if the underwriters’ over-allotment option is exercised in full will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

~~Risks and Uncertainties~~

~~Management continues to evaluate the impact~~ ~~of the COVID-19 pandemic on~~ the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these unaudited condensed financial statements. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 6—~~Shareholders’ Deficit~~

~~Class~~ ~~A Ordinary Shares—~~~~The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share.~~ Derivative Warrant Liabilities

As of ~~September 30, 2020, there were no Class A ordinary shares issued or outstanding.~~

~~Class~~ ~~B Ordinary Shares—~~~~The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. On September 1, 2020,~~March 31, 2022 and December 31, 2021, the Company ~~issued 2,875,000 Class B ordinary shares. On October 12, 2020, the Sponsor effected a surrender~~had an aggregate of ~~431,250 Class B ordinary shares to the Company for no consideration, resulting in a decrease in the total number~~3,396,833 warrants outstanding, comprised of ~~Class B ordinary shares outstanding from 2,875,000 to 2,443,750. All shares~~3,258,333 Public Warrants and associated amounts have been retroactively restated to reflect the share surrender. Of the 2,443,750 Class B ordinary shares outstanding, up to 318,750 shares were subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the initial shareholders would collectively own approximately

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

~~20% of the Company’s issued and outstanding ordinary shares (excluding the~~138,500 Private Placement Shares and assuming the initial shareholders do not purchase any units in the Initial Public Offering) (See Note 4). The underwriters fully exercised the over-allotment option on October 20, 2020; thus, these 318,750 Class B ordinary shares are no longer subject to forfeiture.

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of our shareholders except as required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination or earlier at the option of the holders thereof at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, ~~on an as-converted basis, 20%~~ of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares underlying the Private Placement Units) upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Company’s Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of ~~less than one-to-one.~~

~~Preference Shares~~—The Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of September 30, 2020, there were no preference shares issued or outstanding.

~~Warrants~~—Warrants.

Public Warrants may only be exercised for a whole number of shares. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination, and to maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, the Company will not be required to file or maintain in effect a registration statement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60^th60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but the Company will use its best efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

The warrant has an exercise price of $11.50, subject to adjustments as described herein, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”),

Table of Contents

(y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of Class A ordinary

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

The Private ~~Placement Warrants~~placement units have terms and provisions that are identical to those of the Public Warrants. The Private ~~Placement Warrants~~placement units (including the Class A ordinary shares issuable upon exercise of the Private ~~Placement Warrants)~~placement units) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination (except pursuant to limited exceptions to the officers and directors and other persons or entities affiliated with the initial purchasers of the Private ~~Placement Warrants)~~placement units) and they will not be redeemable by the Company (except as described under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00”) so long as they are held by the Sponsor or its permitted transferees (except as otherwise set forth herein). The Sponsor, or its permitted transferees, has the option to exercise the Private ~~Placement Warrants~~placement units on a cashless basis. If the private ~~Placement Warrants~~placement units are held by holders other than the Sponsor or its permitted transferees, the Private ~~Placement Warrants~~placement units will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the Public Warrants.

Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants (except with respect to the Private ~~Placement Warrants)~~placement units):

in whole and not in part

at a price of $0.01 per warrant;

upon a minimum of 30 days’ prior written notice of redemption; and

if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share ~~splits,~~

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the

30-day

redemption period.

Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00. Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;

•

~~at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption~~ ~~provided~~ that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares;

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of Class A ordinary shares;

if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per Public Share (as adjusted) for any 20 trading days within the

30-trading

day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and

~~TURMERIC ACQUISITION CORP.~~

~~NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS~~

if the closing price of the Class A ordinary shares for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private ~~Placement Warrants~~placement units must also be concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above.

Table of Contents

The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume weighted average price of Class A ordinary shares during the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).

Note 7—Class A Ordinary Shares Subject to Possible Redemption

The Company’s Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. As of March 31, 2022 and December 31, 2021, there were 9,775,000 Class A ordinary shares subject to possible redemption.

As of March 31, 2022 and December 31, 2021, Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets

are

reconciled on the following table:


Gross proceeds	$	97,750,000
Less:
Fair value of Public Warrants at issuance		(3,812,250	)
Offering costs allocated to Class A ordinary shares subject to possible redemption		(5,698,514	)
Plus:
Accretion of carrying value to redemption value		9,510,764
Class A ordinary share subject to possible redemption	$	97,750,000

Note 8—Shareholders’ Deficit

Preference Shares—

The Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2022 and December 31, 2021, there were 0 preference shares issued or outstanding.

Class

A Ordinary Shares—

The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 10,190,500 Class A ordinary shares issued and outstanding, of which 9,775,000 shares were subject to possible redemption that were classified as temporary equity in the accompanying condensed balance sheets (see Note 7).

Class

B Ordinary Shares—

The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. On September 1, 2020, the Company ~~has not completed~~issued 2,875,000 Class B ordinary shares. On October 12, 2020, the Sponsor effected a surrender of 431,250 Class B ordinary shares to the Company for no consideration, resulting in a decrease in the total number of Class B ordinary shares outstanding from 2,875,000 to 2,443,750. All shares and associated amounts have been retroactively restated to reflect the share surrender.

as-converted

basis, 20% of the sum

Table of Contents

of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares underlying the Private Placement Units) upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private placement units issued to the Company’s Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than

one-to-one.

Note 9—Fair Value Measurements

The following tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 and December 31, 2021 by level within the ~~Combination Period~~fair value hierarchy:


	Fair Value Measured as of March 31, 2022
	Level 1		Level 2		Level 3		Total
Assets:
Investments held in Trust Account	$	97,758,689	$	—	$	—	$	97,758,689
Liabilities:
Derivative warrant liabilities - Public warrants	$	1,074,270	$	—	$	—	$	1,074,270
Derivative warrant liabilities - Private warrants	$	—	$	—	$	45,710	$	45,710


	Fair Value Measured as of December 31, 2021
	Level 1		Level 2		Level 3		Total
Assets:
Investments held in Trust Account	$	97,757,245	$	—	$	—	$	97,757,245
Liabilities:
Derivative warrant liabilities - Public warrants	$	2,215,670	$	—	$	—	$	2,215,670
Derivative warrant liabilities - Private warrants	$	—	$	—	$	94,180	$	94,180

Transfers to/from Levels 1, 2, and 3 are recognized at the beginning of the reporting period. There were no transfers between levels of the hierarchy during the three months ended March 31, 2022 and the year ended December 31, 2021.

Level 1 assets include investments in money market funds or U.S. Treasury securities. The Company ~~liquidates~~uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the ~~funds held~~fair value of its investments.

The fair value Private Placement Warrants have been estimated using a Monte Carlo simulation model at each subsequent measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have been measured based on the listed market price of such warrants, a Level 1 measurement. For the three months ended March 31, 2022 and 2021, the Company recognized a gain of approximately $1.2 million and $2.9 million resulting from a decrease in the ~~Trust Account, holders~~fair value of liabilities, presented as change in fair value of derivative warrant liabilities on the accompanying condensed statements of operations.

The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its Class A ordinary shares warrants ~~will not receive any of such funds with respect to their warrants, nor will they receive any distribution~~based on implied volatility from the Company’s ~~assets held outside~~traded warrants and from historical volatility of select peer company’s Class A ordinary shares that matches the expected remaining life of the ~~Trust Account with~~warrants. The risk-free interest rate is based on the ~~respect~~U.S. Treasury

zero-coupon

yield
curve on the grant date for a maturity similar to ~~such~~the expected remaining life of the warrants. ~~Accordingly,~~The expected life of the warrants ~~may expire worthless.~~

is assumed to be
equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The most significant input is volatility and significant increases (decreases) in the expected volatility in isolation would result in a significantly higher
(lower) fair value

measurement.

Table of Contents

The following table provides quantitative information regarding Level 3 fair value measurements inputs for the Company’s Private Placement Warrants as of March 31, 2022 and December 31, 2021:


	March 31, 2022			December 31, 2021
Exercise price	$	11.50		$	11.50
Stock Price	$	9.85		$	9.82
Option term (in years)		5.00			5.00
Volatility		5.5	%		12	%
Risk-free interest rate		2.39	%		1.25	%

The change in the fair value of the derivative warrant liabilities measured utilizing Level 3 inputs for the three months ended March 31, 2022 and 2021, is summarized as follows:



Level 3 derivative warrant liabilities at January 1, 2022	$	94,180
Change in fair value of derivative warrant liabilities		(48,470	)

Level 3 derivative warrant liabilities at March 31, 2022	$	45,710


Level 3 derivative warrant liabilities at January 1, 2021	$	267,310
Change in fair value of derivative warrant liabilities		(124,650	)

Level 3 derivative warrant liabilities at March 31, 202 1		142,660

Note 7—10 — Subsequent Events

~~Management has~~

The Company evaluated subsequent events ~~to determine if events or~~and transactions ~~occurring through November 30, 2020,~~that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were ~~issued, require potential~~issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment to or disclosure in the unaudited condensed financial ~~statements and has concluded that all such events that would require recognition or disclosure have been recognized or disclosed.~~

statements.

~~Item 2. Management’s Discussion and Analysis~~Table of ~~Financial Condition and Results of Operations.~~

Contents

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “our,” “us” or “we” refer to Turmeric Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form
10-Q
includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Form
10-Q.
Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.

Overview

We are a blank check company incorporated as a Cayman Islands exempted company on August 28, 2020 for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Our Sponsor is Turmeric Management, LLC, a Delaware limited liability company (“Sponsor”).

The registration statement for our initial public offering (the “Initial Public Offering’) became effective on October 15, 2020. On October 20, 2020, we consummated the Initial Public Offering of 9,775,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 1,275,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of approximately $97.8 million, and incurring offering costs of approximately $5.9 million, inclusive of approximately $3.4 million in deferred underwriting commissions.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 415,500 units (each, a “Private Placement Unit” and collectively, the “Private Placement Units”), at a price of $10.00 per Private Placement Unit with the Sponsor, generating gross proceeds of approximately $4.2 million.

Upon the closing of the Initial Public Offering and the Private Placement, approximately $97.8 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier ~~of:~~of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

If we have not completed a Business Combination within 24 months from the closing of the Initial Public Offering, or October 20, 2022 (the “Combination Period”), we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including

interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public

Table of Contents

Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our outstanding warrants, which will expire worthless if we fail to consummate a Business Combination within the Combination Period.

~~Results~~

Liquidity and Going Concern

As of ~~Operations~~

Our entire activity from August 28, 2020 (inception) through September 30, 2020, was in preparation for an Initial Public Offering, and since our Initial Public Offering, our activity has been limited to the search for a prospective initial Business Combination. We will not generate any operating revenues until the closing and completion of our initial Business Combination.

~~For the period from August 28, 2020 (inception) through September 30, 2020,~~March 31, 2022, we had ~~a loss of~~ approximately ~~$57,000, which consisted solely of general~~$230,000 in our operating bank account and ~~administrative expenses.~~

~~Liquidity and Capital Resources~~

~~As of September 30, 2020, we had no cash and~~a working capital deficit of approximately ~~$374,000.~~

$437,000.

Our liquidity needs to date have been satisfied through a contribution of $25,000 from our Sponsor to cover certain of our expenses in exchange for the issuance of ~~the issuance of founder~~our Class B ordinary shares ~~to our Sponsor,~~(the “Founder Shares”), a loan of approximately $64,000 from our Sponsor under a promissory note (the “Note”), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Company repaid the Note in full on October 20, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, ~~our~~the Sponsor or an affiliate of ~~our~~the Sponsor, or certain of ~~our~~the Company’s officers and directors may, but are not obligated to, provide usthe Company working capital loans. As of ~~September 30, 2020,~~March 31, 2022, there were no amounts outstanding under any working capital loan.

~~Based~~

In connection with our assessment of going concern considerations in accordance with FASB ASC Topic

205-40,

“Presentation of Financial Statements—Going Concern,” management has determined that the liquidity condition, mandatory liquidation date and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. If we are unable to complete a business combination by October 20, 2022, then we will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after October 20, 2022.

Results of Operations

Our entire activity since inception up to March 31, 2022 related to our formation, the preparation for the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We will not be generating any operating revenues until the closing and completion of our initial Business Combination, at the earliest.

For the three months ended March 31, 2022, we had a net income of approximately $781,000, which consisted of

non-operating

income of approximately $1.2 million resulting from changes in fair value of derivative warrant liabilities and approximately $1,000 income from investments held in Trust account, partially offset by approximately $410,000 of operating expenses, comprised of approximately $380,000 in general and administrative expenses and $30,000 in administrative expenses – related party.

For the three months ended March 31, 2021, we had net income of approximately $2.7 million, which consisted of

a non-operating gain

of approximately $2.9 million for the change in fair value of derivative warrant liabilities and approximately $1,000 income from investments held in Trust account, which was partially offset by approximately $181,000 in general and administrative expenses and $30,000 in administrative expenses – related party.

Contractual Obligations

Administrative Support Agreement

Commencing on the ~~foregoing, management believes that we will have sufficient working capital and borrowing capacity from our Sponsor or an affiliate~~effective date of our ~~Sponsor, or our officers and directors to meet our needs~~prospectus through the earlier of ~~the~~ consummation of athe initial Business Combination or ~~one year from this filing. Over this time period,~~the Company’s liquidation, we will ~~be using these funds~~reimburse our Sponsor for ~~paying existing accounts payable,~~office space, secretarial and administrative services provided to us in the amount of $10,000 per month. In addition, we agreed to reimburse our Sponsor, executive officers and directors, or their respective affiliates for any

out-of-pocket

expenses incurred in connection with activities on our behalf such as identifying potential target businesses and ~~evaluating prospective initial Business Combination candidates,~~ performing due diligence on ~~prospective target businesses, paying~~suitable Business Combinations. Our audit committee will review on a quarterly basis all payments that were made by us to our Sponsor, executive officers or directors, or their affiliates.

Table of Contents

We also agreed to pay (i) the Company’s

non-employee

directors an annual cash retainer of $20,000 and a onetime cash payment of $30,000 to be paid upon the consummation of the initial Business Combination, and (ii) our Chairman will receive an annual cash retainer of $40,000 and a onetime cash payment of $60,000 to be paid upon the consummation of the initial Business Combination. Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, will be paid by us to our Sponsor, executive officers and directors, or their respective affiliates, prior to completion of the initial Business Combination.

Underwriting Agreement

Our underwriters were entitled to an underwriting discount of $0.20 per Unit, or approximately $2.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $3.4 million in the aggregate will be payable to the underwriters for ~~travel expenditures, selecting~~deferred underwriting commissions. The deferred fee will become payable to the ~~target business~~underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to ~~merge with or acquire, and structuring, negotiating and consummating~~ the ~~Business Combination.~~

~~Contractual Obligations~~

~~We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.~~

terms of the underwriting agreement.

Critical Accounting Policies

~~This management’s discussion and analysis~~

The preparation of ~~our financial condition and results of operations is based on our unaudited condensed~~ financial statements ~~which have been prepared~~ in accordance with ~~U.S. GAAP. The preparation~~accounting principles generally accepted in the United States of ~~these unaudited condensed financial statements~~America requires usmanagement to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and ~~expenses~~expenses. A summary of our significant accounting policies is included in Note 2 to our condensed financial statements in Part I, Item 1 of this Quarterly Report. Certain of our accounting policies are considered critical, as these policies are the most important to the depiction of our condensed financial statements and require significant, difficult or complex judgments, often employing the ~~disclosure~~use of ~~contingent assets~~estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management’s Discussion and ~~liabilities~~Analysis of Financial Condition and Results of Operations section in our ~~financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates~~2021 Annual Report on ~~historical experience, known trends and events and various other factors that we believe to be reasonable under~~Form

10-K

filed with the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.SEC on March 29, 2022. There have been no significant changes in the application of our critical accounting policies ~~as discussed in~~during the ~~Form~~ ~~8-K~~ ~~and the final prospectus filed by us with the SEC on October 26, 2020 and October 16, 2020, respectively.~~

three months ended March 31, 2022.

Recent Accounting Pronouncements

~~Our management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on~~

See Note 2 to the ~~accompanying~~ unaudited condensed financial ~~statements.~~

statements included in Part I, Item 1 of this Quarterly Report for a discussion of recent accounting pronouncements.

Off-Balance Sheet Arrangements

As of ~~September 30, 2020,~~March 31, 2022, we

did not have any off-balance sheet arrangements as defined

in Item 303(a)(4)(ii) of Regulation

S-K.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for

non-emerging

growth companies. As a result, the ~~unaudited~~ condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of

non-emerging

growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons

Table of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Contents~~Item 3. Quantitative and Qualitative Disclosures About Market Risk~~

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by

Rule 12b-2 of

the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information otherwise required under this item.

~~Item 4. Controls and Procedures~~

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls are procedures that are designed to ensure that information required to be disclosed by us in our Exchange Act is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial ~~and accounting~~ officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the ~~fiscal~~period quarter ~~ended September 30, 2020,~~March 31, 2022, as such term is defined in Rules

13a-15(e)

and

15d-15(e)

under the Exchange Act. Based on this evaluation, our ~~chief executive officer and chief financial officer have concluded that during the period covered by this report, our disclosure controls and procedures were effective.~~

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer has concluded that, as of the evaluation date, our disclosure controls and procedures were not effective as of March 31, 2022, because of a material weakness in our internal control over financial reporting. A material weakness is a deficiency, or ~~persons performing similar functions,~~a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, the Company’s management has concluded that our control around the interpretation and accounting for certain complex equity and equity-linked instruments issued by the Company and the presentation of earnings per share was not effectively designed or maintained. This material weakness resulted in the restatement of the Company’s audited balance sheet as ~~appropriate~~of October 20, 2020, its annual financial statements for the period ended December 31, 2020 and its interim financial statements and Notes as reported in its SEC filings for the quarters ended September 30, 2020, March 31, 2021 and June 30, 2021. In light of this material weakness, we performed additional analysis as deemed necessary to ~~allow timely decisions regarding required disclosure.~~

ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report on Form

10-Q

present fairly in all material respects our financial position, results of operations and cash flows for the periods presented.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the ~~period from August 28, 2020 (inception) through September 30, 2020,~~quarter ended March 31, 2022 covered by this Quarterly Report on Form

10-Q

that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting except for the below:

Our principal executive officer and principal financial officer performed additional accounting and financial analyses and other post-closing procedures including consulting with subject matter experts related to the accounting for certain complex equity and equity-linked instruments issued by the Company and the presentation of earnings per share. The Company’s management has expended, and will continue to expend, a substantial amount of effort and resources for

Table of Contents

the remediation and improvement of our internal control over financial reporting.

While we have processes to properly identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we have expanded and will continue to improve these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards.

Table of Contents

PART II – OTHER INFORMATION

~~Item 1. Legal Proceedings~~

Item 1.

Legal Proceedings

None.

Item 1A. Risk Factors.

~~There~~

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in Part I, Item 1A of our Annual Report on Form

10-K

filed with the SEC on March 29, 2022. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes ~~from~~to the risk factors ~~previously~~ disclosed in ~~the Company’s final prospectus for the Initial Public Offering as~~ our Annual Report on Form

10-K

filed with the SEC on ~~October 16, 2020.~~

March 29, 2022, except as set forth below. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Changes in laws or regulations, or a failure to comply with any laws or regulations, may adversely affect our business, investments and results of operations.

We are subject to laws and regulations enacted by national, regional and local governments. In particular, we are required to comply with certain SEC and other legal requirements. Compliance with, and monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time and those changes could have a material adverse effect on our business, investments and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an initial business combination, and results of operations.

On March 30, 2022, the SEC issued proposed rules relating to, among other items, enhancing disclosures in business combination transactions involving SPACs and private operating companies; amending the financial statement requirements applicable to transactions involving shell companies; effectively limiting the use of projections in SEC filings in connection with proposed business combination transactions; increasing the potential liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act of 1940. These rules, if adopted, whether in the form proposed or in revised form, may materially adversely affect our ability to negotiate and complete our initial business combination and may increase the costs and time related thereto.

Item 2. Unregistered Sales of Equity Securities and Use of ~~Proceeds from Registered Securities~~

~~Unregistered Sales~~

On September 1, 2020, our Sponsor paid $25,000 to cover certain of our expenses in consideration of 2,875,000 Class B ordinary shares, par value $0.0001, (the “Founder Shares”). On October 12, 2020, our Sponsor effected a surrender of 431,250 Class B ordinary shares to us for no consideration, resulting in a decrease in the total number of Class B ordinary shares outstanding from 2,875,000 to 2,443,750. Our Sponsor agreed to forfeit up to 318,750 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of our issued and outstanding ordinary shares (excluding the Private Placement Shares and assuming the initial shareholders do not purchase any units in the Initial Public Offering) after the Initial Public Offering. On September 25, 2020, our Sponsor transferred 25,000 Class B ordinary shares to each of ~~the non-employee directors~~ and 45,000 Class B ordinary shares to Matthew Roden, as Chairman. On September 30, 2020, our Sponsor transferred 17,500 Class B ordinary shares to Vinay Bhaskar. The underwriters fully exercised the over-allotment option on October 20, 2020; thus, these Founder Shares are no longer subject to forfeiture. Such securities were issued in connection with the Company’s organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

On October 20, 2020, our Sponsor purchased 415,500 Private Placement Units, at a price of $10.00 per Private Placement Unit, generating gross proceeds of approximately $4.2 million, in a private placement that closed simultaneously with the closing of the Initial Public Offering. This issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

~~No underwriting discounts or commissions were paid with respect to such sales.~~

~~Use of Proceeds~~

On October 20, 2020, we consummated the Initial Public Offering of 9,775,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), including 1,275,000 additional Units to cover over-allotments (the “Over-Allotment Units”), at $10.00 per Unit, generating gross proceeds of approximately $97.8 million, and incurring offering costs of approximately $5.9 million, inclusive of approximately $3.4 million in deferred underwriting commissions.

In connection with the Initial Public Offering, we incurred offering costs of approximately $5.9 million, inclusive of approximately $3.4 million in deferred underwriting commissions. Other incurred offering costs consisted principally of preparation fees related to the Initial Public Offering. After deducting the underwriting discounts and commissions

Proceeds.

(excluding the deferred portion, which amount will be payable upon consummation of the Initial Business Combination, if consummated) and the Initial Public Offering expenses, $97.8 million of the net proceeds from our Initial Public Offering and certain of the proceeds from the private placement of the Private Placement Warrants (or $10.00 per Unit sold in the Initial Public Offering) was placed in the Trust Account. The net proceeds of the Initial Public Offering and certain proceeds from the sale of the Private Placement Warrants are held in the Trust Account and invested as described elsewhere in this Quarterly Report on ~~Form 10-Q.~~

There has been no material change in the planned use of the proceeds from the Initial Public Offering and Private Placement as is described in the Company’s final prospectus related to the Initial Public Offering.

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Table of Contents

Item 6. ~~Exhibits.~~

Exhibits


Exhibit Number		Description

31.1		Certification of Chief Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

~~101.INS~~101.INS*		Inline XBRL Instance Document

~~101.SCH~~101.SCH*		Inline XBRL Taxonomy Extension Schema Document

~~101.CAL~~101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document

~~101.DEF~~101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document

~~101.LAB~~101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document

~~101.PRE~~101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized on this ~~30th~~

13th

day of ~~November 2020.~~

May 2022.


TURMERIC ACQUISITION CORP.

By:		/s/ Luke Evnin
Name:		Luke Evnin
Title:		Chief Executive Officer


Assets
Deferred offering costs	$	342,148

Total Assets	$	342,148


Liabilities and Shareholders’ Deficit
Current liabilities
Accounts payable	$	39,496
Accrued expenses		270,280
Notes payable - related party		64,177

Total current liabilities		373,953

Commitments and Contingencies

Shareholders’ Deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding		—
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; no shares issued and outstanding		—
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 2,443,750 shares issued and outstanding		244
Additional paid-in capital		24,756
Accumulated deficit		(56,805	)

Total shareholders’ deficit		(31,805	)

Total Liabilities and Shareholders’ Deficit	$	342,148


	March 31, 2022			December 31, 2021
	(unaudited)
Assets
Current assets
Cash and cash equivalents	$	229,835		$	425,270
Prepaid expenses		123,375			121,204

Total current assets		353,210			546,474
Investments held in Trust Account		97,758,689			97,757,245

Total Assets	$	98,111,899		$	98,303,719

Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit
Current liabilities
Accounts payable	$	289,524		$	215,764
Accrued expenses		490,268			329,151
Due to related party		10,000			27,900

Total current liabilities		789,792			572,815
Derivative warrant liabilities		1,119,980			2,309,850
Deferred underwriting commissions		3,421,250			3,421,250

Total Liabilities		5,331,022			6,303,915
Commitments and Contingencies	0			0
Class A ordinary shares subject to possible redemption, $0.0001 par value; 9,775,000 shares at redemption value of $10.00 per share as of March 31, 2022 and December 31, 2021		97,750,000			97,750,000
Shareholders’ Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; 0ne issued or outstanding as of March 31, 2022 and December 31, 2021		0			0
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 415,500 shares issued and outstanding as of March 31, 2022 and December 31, 2021		42			42
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 2,443,750 shares issued and outstanding as of March 31, 2022 and December 31, 2021		244			244
Additional paid-in capital		0			0
Accumulated deficit		(4,969,409	)		(5,750,482	)

Total Shareholders’ Deficit		(4,969,123	)		(5,750,196	)

Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit	$	98,111,899		$	98,303,719


General and administrative expenses	$	56,805

Loss from operations		(56,805	)

Net loss	$	(56,805	)

Weighted average shares outstanding, basic and diluted		2,443,750

Basic and diluted net loss per share	$	(0.02	)


	Three Months Ended March 31,
	2022			2021
Operating expenses:
General and administrative expenses	$	380,241		$	180,989
Administrative fee - related party		30,000			30,000

Loss from operations		(410,241	)		(210,989	)
Other income:
Change in fair value of derivative warrant liabilities		1,189,870			2,894,233
Net income earned on investments held in Trust Account		1,444			1,444

Net income	$	781,073		$	2,684,688

Weighted average shares outstanding of Class A ordinary shares, basic and diluted		10,190,500			10,190,500

Basic and diluted net income per share, Class A ordinary shares	$	0.06		$	0.21

Weighted average shares outstanding of Class B ordinary shares, basic and diluted		2,443,750			2,443,750

Basic and diluted net income per share, Class B, ordinary shares	$	0.06		$	0.21


	Ordinary Shares								Additional Paid-in Capital					Total Shareholders’ Deficit
	Class A				Class B						Accumulated Deficit
	Shares		Amount		Shares		Amount				Accumulated Deficit
Balance - August 28, 2020 (inception)		—	$	—		—	$	—	$	—	$	—		$	—
Issuance of Class B ordinary shares to Sponsor		—		—		2,443,750		244		24,756		—			25,000
Net loss (unaudited)		—		—		—		—		—		(56,805	)		(56,805	)

Balance - September 30, 2020 (unaudited)		—	$	—		2,443,750	$	244	$	24,756	$	(56,805	)	$	(31,805	)


	Ordinary Shares								Additional					Total
	Class A				Class B				Paid-in		Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance - December 31, 2021		415,500	$	42		2,443,750	$	244	$	0	$	(5,750,482	)	$	(5,750,196	)
Net income		—		—		—		—		0		781,073			781,073

Balance - March 31, 2022 (unaudited)		415,500	$	42		2,443,750	$	244	$	0	$	(4,969,409	)	$	(4,969,123	)


Cash Flows from Operating Activities:
Net loss	$	(56,805	)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares		25,000
General and administrative expenses paid by Sponsor under note payable		23,500
Changes in operating assets and liabilities:
Accrued expenses		8,305

Net cash used in operating activities		—

Net increase in cash		—
Cash - beginning of the period		—

Cash - end of the period	$	—

Supplemental disclosure of noncash financing activities:
Deferred offering costs included in accounts payable	$	39,496
Deferred offering costs included in accrued expenses	$	261,975
Deferred offering costs included in note payable - related party	$	40,677


	For t he Three Months Ended March 31, 2022				For t he Three Months Ended March 31, 2021
	Class A		Class B		Class A		Class B
Basic and diluted net income per ordinary share:
Numerator:
Allocation of net income	$	629,996	$	151,077	$	2,165,409	$	519,279
Denominator:
Basic and diluted weighted average ordinary shares outstanding		10,190,500		2,443,750		10,190,500		2,443,750

Basic and diluted net income per ordinary share	$	0.06	$	0.06	$	0.21	$	0.21